Want to see CON full AI Analyst Report?
CON Stock Chart & Stats
$22.86
$0.10(0.50%)
At close: 4:00 PM EST
$22.86
$0.10(0.50%)
Day’s Range― - ―
52-Week Range$18.55 - $32.35
Previous CloseN/A
Volume132.54K
Average Volume (3M)1.02M
Market Cap
$4.04B
Enterprise Value$5.69B
Total Cash (Recent Filing)$61.70M
Total Debt (Recent Filing)$2.12B
Price to Earnings (P/E)22.6
Beta0.53
Next Earnings
Aug 06, 2026EPS Estimate
0.42Next Dividend Ex-DateN/A
Dividend Yield1.27%
Share Statistics
EPS (TTM)1.39
Shares Outstanding127,961,780
10 Day Avg. Volume1,012,936
30 Day Avg. Volume1,016,203
Financial Highlights & Ratios
PEG Ratio2.05
Price to Book (P/B)6.34
Price to Sales (P/S)1.15
P/FCF Ratio12.65
Enterprise Value/Market Cap1.41
Enterprise Value/Revenue2.55
Enterprise Value/Gross Profit9.18
Enterprise Value/Ebitda13.22
Forecast
1Y Price Target
$32.00Price Target Upside39.98% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)1.51
Revenue Forecast (FY)$2.33B
Bulls Say, Bears Say
Bulls Say
Free Cash Flow StrengthReliable and material free cash flow (TTM ~ $293M) provides durable internal funding for capex, M&A, dividends and buybacks. Persistent FCF coverage near parity with net income signals quality of earnings and underpins management's ability to deleverage and invest over the next several quarters.
Sustained Revenue MomentumMulti-year revenue expansion demonstrates structural demand for occupational and on-site health services. Growth across years and in visit volumes supports scalable operating leverage, making organic top-line momentum a durable driver of profitability and network value over the medium term.
Successful M&A & On‑site ScaleRapid, accretive integrations and a sharp on‑site clinic run‑rate ramp demonstrate repeatable M&A execution and scalable new channels. These structural wins expand service reach, diversify revenue mix, and create long‑term synergies that should sustain margin and growth potential.
Bears Say
Elevated LeverageMaterial leverage volatility increases financial risk and sensitivity to cash flow swings. High absolute debt constrains strategic flexibility, raises refinancing and interest exposure, and makes sustained deleveraging essential to avoid crowding out investments or shareholder returns over the coming quarters.
Margin Pressure (TTM)A notable TTM decline in EBITDA margin signals emerging cost, mix, or timing headwinds that could blunt operating leverage. If persistent, margin compression will reduce free cash flow conversion and slow the pace of deleveraging and capital returns even as revenue grows.
Employer Services & Separation CostsSlower employer‑services growth and elevated G&A tied to separation and IT build introduce execution and cost risks. These structural investments increase the run‑rate cost base near term and may delay margin normalization if employer services recovery or expected mix benefits are slower than planned.
Concentra Group Holdings Parent, Inc. News
CON FAQ
What was Concentra Group Holdings Parent, Inc.’s price range in the past 12 months?
Concentra Group Holdings Parent, Inc. lowest stock price was $18.55 and its highest was $32.35 in the past 12 months.
What is Concentra Group Holdings Parent, Inc.’s market cap?
Concentra Group Holdings Parent, Inc.’s market cap is $4.04B.
When is Concentra Group Holdings Parent, Inc.’s upcoming earnings report date?
Concentra Group Holdings Parent, Inc.’s upcoming earnings report date is Aug 06, 2026 which is in 24 days.
How were Concentra Group Holdings Parent, Inc.’s earnings last quarter?
Concentra Group Holdings Parent, Inc. released its earnings results on May 07, 2026. The company reported $0.4 earnings per share for the quarter, beating the consensus estimate of $0.338 by $0.062.
Is Concentra Group Holdings Parent, Inc. overvalued?
According to Wall Street analysts Concentra Group Holdings Parent, Inc.’s price is currently Undervalued.
Does Concentra Group Holdings Parent, Inc. pay dividends?
Concentra Group Holdings Parent, Inc. pays a Quarterly dividend of $0.063 which represents an annual dividend yield of 1.27%. See more information on Concentra Group Holdings Parent, Inc. dividends here
What is Concentra Group Holdings Parent, Inc.’s EPS estimate?
Concentra Group Holdings Parent, Inc.’s EPS estimate is 0.42.
How many shares outstanding does Concentra Group Holdings Parent, Inc. have?
Concentra Group Holdings Parent, Inc. has 127,961,780 shares outstanding.
What happened to Concentra Group Holdings Parent, Inc.’s price movement after its last earnings report?
Concentra Group Holdings Parent, Inc. reported an EPS of $0.4 in its last earnings report, beating expectations of $0.338. Following the earnings report the stock price went up 2.373%.
Which hedge fund is a major shareholder of Concentra Group Holdings Parent, Inc.?
Currently, no hedge funds are holding shares in CON
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Concentra Group Holdings Parent, Inc. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$32.00 (39.98% Upside)
$32.00 (39.98% Upside)
Blogger Sentiment
Bullish
CON Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 153.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $10.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.2%
Last 30 Days ▼ 0.6%
Last 30 Days ▼ 0.6%
Technicals
SMA
Positive
20 days / 200 days
Momentum
55.60%
12-Months-Change
Fundamentals
Return on Equity
46.05%
Trailing 12-Months
Asset Growth
5.88%
Trailing 12-Months
Company Description
Concentra Group Holdings Parent, Inc.
Concentra Group Holdings Parent, Inc. is a U.S.-based provider of occupational health solutions. The company delivers a comprehensive suite of occupational and consumer health services, encompassing treatment for workers' compensation injuries, urgent care, diagnostic clinical testing, preventative health measures, and employer-specific programs, along with wellness initiatives. These services are accessible through their network of occupational health centers and onsite clinics. Furthermore, Concentra offers specialized solutions like Concentra Telemed, a telemedicine platform for addressing work-related injuries and illnesses and supporting employer services; Concentra Pharmacy, providing pharmaceutical solutions; and Concentra Medical Compliance Administration, a third-party administrative service that assists employers in managing drug abuse testing programs for both regulated and non-regulated workforces. Established in 1979 and headquartered in Mechanicsburg, Pennsylvania, the company functions as a subsidiary of Select Medical Corporation.
CON Company Deck
CON Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a broadly positive picture: revenue, visit volumes, adjusted EBITDA, margins, and free cash flow all improved materially year‑over‑year, and management raised 2026 guidance. Strategic M&A integrations (Nova and Pivot) are ahead of plan and on‑site clinic growth is accelerating. Offsetting items include modestly higher adjusted G&A tied to separation and investments, elevated absolute debt and leverage that management is working to reduce, and slower employer services growth and state rate timing/mix headwinds. Overall, the positive operational and financial momentum and raised guidance outweigh the manageable challenges.View all CON earnings summariesCON Stock 12 Month Forecast
Average Price Target
$32.00
▲(39.98% Upside)
Technical Analysis
Labcorp Holdings
―
Envista Holdings
―
Safe Pro Group, Inc.
―
Flowco Holdings Inc Class A
―
Beta Bionics, Inc.
―
Ownership Overview
7.92% Insiders
34.04% Mutual Funds
0.07% Other Institutional Investors
33.30% Public Companies and
Individual Investors